Stealth start-up Quench among teams tying protein to inflammatory cell death

Atlas Venture-backed start-up Quench Bio has partnered with a Max Planck Institute for Infection Biology team to target an inflammatory cell death pathway implicated in inflammatory and autoimmune diseases.

The company, which is funded by Atlas and Arix Bioscience plc (LSE:ARIX), is developing compounds that inhibit highly inflammatory processes in

Read the full 491 word article

User Sign In